Vaginal CO2 laser therapy for genitourinary syndrome in breast cancer survivors—VagLaser study protocol: a randomized blinded, placebo-controlled trial
Abstract Background Vaginal CO2 laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is problematic in these women. The obje...
Main Authors: | Sine Jacobsen, Marianne Glavind-Kristensen, Anders Bonde Jensen, Axel Forman, Pinar Bor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11656-x |
Similar Items
-
Induced Dryness Stress on Human Vaginal Epithelium: The Efficacy of a New Vaginal Gel
by: Guglielmo Stabile, et al.
Published: (2021-09-01) -
Genitourinary syndrome of menopause: optimization of therapyfor vaginal symptoms
by: E G Eprikyan, et al.
Published: (2018-06-01) -
Fractional CO<sub>2</sub> Laser Treatment Is Safe and Effective for the Management of Genitourinary Syndrome of Menopause in Korean Women
by: Youn-Jee Chung, et al.
Published: (2023-05-01) -
Genitourinary menopausal syndrome: diagnosis and treatment principles
by: E. I. Ermakova
Published: (2019-10-01) -
“Modified Schirmer Test” as an Objective Measurement for Vaginal Dryness: A Prospective Cohort Study
by: Dana Gabrieli, et al.
Published: (2022-02-01)